Key Market Indicators
Sweden is projected to maintain its high vaccination coverage for children aged 1 year old, with a stable rate of 98% expected to persist through 2028. This figure remains unchanged from the 98% coverage recorded in 2023. Since 1985, the vaccination rate in Sweden has seen a modest annual increase of 0.2 percentage points. On the export front, Sweden's vaccine exports are forecasted to grow to approximately $26.8 million by 2028, up from $24.8 million in 2023. This represents an average annual growth rate of 1.1%. Since 1997, the country's vaccine supply has experienced a yearly increase of 2.9%. Despite this growth, Sweden ranked 24th in vaccine exports in 2023, with Bulgaria surpassing it at $24.8 million. Belgium, the United Kingdom, and France held the 2nd, 3rd, and 4th positions, respectively, in the same ranking. In terms of imports, Sweden's vaccine imports are expected to rise to about $88.7 million by 2028, up from $83.4 million in 2023. This indicates a yearly average growth rate of 0.9%. Since 1997, Swedish demand for vaccines has increased by 0.3% annually.
